Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-057879
Filing Date
2024-05-10
Accepted
2024-05-10 16:31:06
Documents
5
Effectiveness Date
2024-05-10

Document Format Files

Seq Description Document Type Size
1 S-8 clsd_s-8_10may2024.htm S-8 95863
2 EX-5.1 clsd-ex5_1.htm EX-5.1 14327
3 EX-23.1 clsd-ex23_1.htm EX-23.1 3913
4 EX-FILING FEES clsd-exfiling_fees.htm EX-FILING FEES 32735
5 GRAPHIC img3420020_0.jpg GRAPHIC 29364
  Complete submission text file 0000950170-24-057879.txt   188482
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279334 | Film No.: 24935459
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)